Scripta Therapeutics is a techbio company using AI and multi-omics to identify and develop novel therapeutics by targeting transcription factors that drive disease, initially focusing on neurodegenerative diseases such as Alzheimer’s,Parkinson’s and ALS. (scriptatherapeutics.com)
Company built with Oxford University and Oxford Science Enterprises
Oxford,United Kingdom